In one study, GBA1-PD was characterized by a more aggressive progression and reduced survival rates compared to non-carriers (41), however, in another longitudinal study evaluating AJ patients, no significant effect on survival of either severe or mild variants was detected (50). The gene discussed is GBA1; the disease is Parkinson disease.